van Kemenade FJ - Search Results

1

Impact of Reclassification of Oncocytic and Follicular Thyroid Carcinoma by the 2022 WHO Classification.

Stegenga MT, Oudijk L, van Velsen EFS, Peeters RP, Medici M, Verburg FA, van Ginhoven TM, van Kemenade FJ, Visser WE. Stegenga MT, et al. Among authors: van kemenade fj. J Clin Endocrinol Metab. 2024 Aug 21:dgae581. doi: 10.1210/clinem/dgae581. Online ahead of print. J Clin Endocrinol Metab. 2024. PMID: 39166490

2

Acute Candida thyroiditis complicated by abscess formation in a severely immunocompromised patient.

Massolt ET, Rijneveld AW, Vernooij MW, Kevenaar ME, van Kemenade FJ, Peeters RP. Massolt ET, et al. Among authors: van kemenade fj. J Clin Endocrinol Metab. 2014 Nov;99(11):3952-3. doi: 10.1210/jc.2014-2528. Epub 2014 Jul 17. J Clin Endocrinol Metab. 2014. PMID: 25033071 No abstract available.

3

Sorafenib-Induced Changes in Thyroid Hormone Levels in Patients Treated for Hepatocellular Carcinoma.

Beukhof CM, van Doorn L, Visser TJ, Bins S, Visser WE, van Heerebeek R, van Kemenade FJ, de Rijke YB, de Herder WW, Chaker L, Mathijssen RH, Peeters RP. Beukhof CM, et al. Among authors: van doorn l, van kemenade fj, van heerebeek r. J Clin Endocrinol Metab. 2017 Aug 1;102(8):2922-2929. doi: 10.1210/jc.2016-4025. J Clin Endocrinol Metab. 2017. PMID: 28575418

4

Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.

van Velsen EFS, Stegenga MT, van Kemenade FJ, Kam BLR, van Ginhoven TM, Visser WE, Peeters RP. van Velsen EFS, et al. Among authors: van ginhoven tm, van kemenade fj. Thyroid. 2018 Aug;28(8):976-981. doi: 10.1089/thy.2018.0066. Epub 2018 Jul 30. Thyroid. 2018. PMID: 29848239

5

Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.

van Velsen EFS, Stegenga MT, van Kemenade FJ, Kam BLR, van Ginhoven TM, Visser WE, Peeters RP. van Velsen EFS, et al. Among authors: van ginhoven tm, van kemenade fj. Thyroid. 2019 Aug;29(8):1073-1079. doi: 10.1089/thy.2019.0053. Epub 2019 Jul 17. Thyroid. 2019. PMID: 31140385

6

Evaluation of the 2015 ATA Guidelines in Patients With Distant Metastatic Differentiated Thyroid Cancer.

van Velsen EFS, Stegenga MT, van Kemenade FJ, Kam BLR, van Ginhoven TM, Visser WE, Peeters RP. van Velsen EFS, et al. Among authors: van ginhoven tm, van kemenade fj. J Clin Endocrinol Metab. 2020 Mar 1;105(3):e457-65. doi: 10.1210/clinem/dgz137. J Clin Endocrinol Metab. 2020. PMID: 31665318 Free PMC article.

7

Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.

van Velsen EFS, Visser WE, Stegenga MT, Mäder U, Reiners C, van Kemenade FJ, van Ginhoven TM, Verburg FA, Peeters RP. van Velsen EFS, et al. Among authors: van ginhoven tm, van kemenade fj. Thyroid. 2021 Jul;31(7):1041-1049. doi: 10.1089/thy.2020.0615. Epub 2021 Mar 4. Thyroid. 2021. PMID: 33487121

8

The influence of age on disease outcome in 2015 ATA high-risk differentiated thyroid cancer patients.

van Velsen EFS, Peeters RP, Stegenga MT, van Kemenade FJ, van Ginhoven TM, Verburg FA, Visser WE. van Velsen EFS, et al. Among authors: van ginhoven tm, van kemenade fj. Eur J Endocrinol. 2021 Aug 3;185(3):421-429. doi: 10.1530/EJE-21-0365. Eur J Endocrinol. 2021. PMID: 34242181

9

How to Differentiate Benign from Malignant Adrenocortical Tumors?

Viëtor CL, Creemers SG, van Kemenade FJ, van Ginhoven TM, Hofland LJ, Feelders RA. Viëtor CL, et al. Among authors: van ginhoven tm, van kemenade fj. Cancers (Basel). 2021 Aug 30;13(17):4383. doi: 10.3390/cancers13174383. Cancers (Basel). 2021. PMID: 34503194 Free PMC article. Review.

10

Evaluating the use of a two-step age-based cutoff for the UICC/AJCC TNM staging system in patients with papillary or follicular thyroid cancer.

van Velsen EFS, Peeters RP, Stegenga MT, Mäder U, Reiners C, van Kemenade FJ, van Ginhoven TM, Visser WE, Verburg FA. van Velsen EFS, et al. Among authors: van ginhoven tm, van kemenade fj. Eur J Endocrinol. 2022 Feb 9;186(3):389-397. doi: 10.1530/EJE-21-1056. Eur J Endocrinol. 2022. PMID: 35038308

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters